Many Early Onset Colon Cancers are Caused by Genetic Mutations Passed Through Families

(April 25, 2018)

CancerConnect News: One in every six colorectal cancer patients (16 percent) diagnosed under age 50 has at least one inherited genetic mutation that increases his or her cancer risk and many of these mutations could go undetected with the current screening... Continue Reading


Managing Side Effects From EGFR Inhibitors

(April 10, 2018)

CancerConnect News: Epidermal Growth Factor Receptor (EGFR) inhibitor drugs are a type of precision cancer medicine commonly used to treat lung, colon, head and neck and other cancers that over express the EGFR.  There are several EGFR inhibitor drugs... Continue Reading


Diagnosed with Colon Cancer: 10 Tips on How to Get The Most From Your Doctor

(February 21, 2018)

1) Choose Your Doctor Carefully Medical oncologists are the primary doctors involved with colon cancer and work in collaboration with surgeons and gastroenterologists. Pick a medical oncologist carefully, rely on people you trust including nurses and... Continue Reading


Ulixertinib A First-in-class ERK Inhibitor Shows Early Efficacy in Patients With Advanced Cancers

(January 8, 2018)

CancerConnect News: The novel ERK1/2 kinase inhibitor ulixertinib displayed an acceptable safety profile and had clinical activity in patients whose cancers had mutations in the MAPK cell-signaling pathway, according to data from a recent phase 1 clinical... Continue Reading


Start 2018 Right: Plan for Cancer Screening and Save Lives!

(January 5, 2018)

Screening guidelines should initiate conversations with your healthcare team.  Charles H Weaver MD, Editor CancerConnect CancerConnect News: The goal of cancer screening is to find disease at early stages in people who are otherwise asymptomatic—before... Continue Reading


Targeting both BRAF and EGFR doubles progression-free survival in metastatic colorectal cancer

(October 16, 2017)

Recent successes in genetically targeted precision cancer medicines are improving outcomes in a number of cancers.  Ensuring patients undergo genomic sequencing to determine if they have treatable targets is increasingly important to ensure patients... Continue Reading


NSAIDs Decrease Risk of Colorectal Cancer

(September 18, 2017)

Nonsteroidal anti-inflammatory drugs (NSAIDS) are medicines that are used for the treatment of a wide range of musculoskeletal illnesses including spinal disorders, osteoarthritis and inflammatory conditions like rheumatoid arthritis. NSAIDs effectively... Continue Reading


Latest Colon Cancer News By Stage


Adjuvant (I-III, A-C) Colon Cancer

Sorry, there are no articles available for this cancer stage.

More Adjuvant (I-III, A-C) Colon Cancer

Screening/Prevention Colon Cancer

Sorry, there are no articles available for this cancer stage.

More Screening/Prevention Colon Cancer

Stage IV (D)/Relapsed Colon Cancer

Sorry, there are no articles available for this cancer stage.

More Stage IV (D)/Relapsed Colon Cancer